In OCD treatment is based on –
**Core Concept**
Serotonin reuptake inhibitors (SRIs) are the primary pharmacological treatment for obsessive-compulsive disorder (OCD). This treatment approach targets the serotonergic system, which is implicated in the pathophysiology of OCD.
**Why the Correct Answer is Right**
The mechanism of SRIs in OCD involves the inhibition of serotonin reuptake by the presynaptic neuron, thereby increasing the concentration of serotonin in the synaptic cleft. This increase in serotonin levels enhances the activity of the serotonergic system, which is thought to be deficient in individuals with OCD. The serotonergic system, particularly the 5-HT1A receptor, plays a crucial role in regulating anxiety and obsessive-compulsive behaviors. By increasing serotonin levels, SRIs can help alleviate these symptoms.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not accurately represent the primary pharmacological treatment for OCD. While other medications may be used as adjuncts or in specific circumstances, SRIs are the first-line treatment for OCD.
**Option B:** This option is incorrect as it is not directly related to the treatment of OCD. While anxiolytics may be used to treat anxiety symptoms, they are not the primary treatment for OCD.
**Option C:** This option is incorrect as it is not a specific type of medication used to treat OCD. While certain medications may have off-label uses, this option is too vague to be the correct answer.
**Clinical Pearl / High-Yield Fact**
It's essential to remember that the treatment of OCD often requires a combination of pharmacological and psychotherapeutic interventions, such as cognitive-behavioral therapy (CBT). CBT, particularly exposure and response prevention (ERP), has been shown to be highly effective in treating OCD.
**Correct Answer: A. Serotonin reuptake inhibitors (SRIs) are the primary pharmacological treatment for OCD.**